Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

Presentation TCT 2016

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Presenter: Adrian P. Banning, Ryan D. Madder, Ziad A. Ali

November 01, 2016

Presentation TCT 2016

Optimizing Fluid Administration for Contrast Nephropathy Prevention

Presenter: Somjot S. Brar, Richard Solomon

November 01, 2016

Presentation TCT 2016

Contrast Reduction Strategies in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Presentation TCT 2016

CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist

Presenter: Somjot S. Brar, Richard Solomon, Anand Prasad

November 01, 2016

Presentation

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Presenter: G. Qian

December 08, 2015

Presentation TCT 2015

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Somjot S. Brar, Richard Solomon, Carlo Briguori

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Presenter: Somjot S. Brar, Richard Solomon, Philippe Généreux

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

Presentation TCT 2014

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

Presenter: Patrick W. Serruys, Huay Cheem Tan

September 13, 2014

Presentation TCT 2013

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Somjot Brar

October 30, 2013

Presentation TCT 2013

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

Presenter: Carlo Briguori

October 30, 2013

Advertisement

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Optimizing Fluid Administration for Contrast Nephropathy Prevention

Contrast Reduction Strategies in the Patient With CKD

Planning and Performing TAVR in the Patient With CKD

CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist

Prevention of Contrast-Induced Nephropathy by Central Venous Pressure (CVP)-Guided Fluid Administration

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Convince Me in 5 Minutes or Less That: Sodium Bicarbonate Is Still Relevant and Might Impact Mortality!

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Impact of Contrast Nephropathy on Medical Management After PCI and on Early Outcomes

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content